DRL

Location

Vlaams Brabant

Founded

1980-09-05

Risk Signals

105 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Furniture, Catalog and Mail-Order Houses), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about DRL

Live alerts from global media, monitored by Business Radar

Costco comes to the bay: How a startup and DRL are taking deliveries to rural customers |  News

2022-06-19 (cbc.ca)

Costco comes to the bay: How a startup and DRL are taking deliveries to rural customers | News

With gas and food prices continuing to hit record-breaking highs, many Newfoundlanders who live outside of the proverbial overpass will no longer have to trek to St. John's to stock up on bulk goods at Costco.

Read more
Dr Reddy's Entrance Into Cannabis Industry Likely To Bring More Indian Big-Pharma Investment -

2022-03-22 (businessofcannabis.com)

Dr Reddy's Entrance Into Cannabis Industry Likely To Bring More Indian Big-Pharma Investment -

INDIA'S fourth largest pharmaceutical company Dr Reddy's Labs (DRL), became the latest big-pharma company to break ground in the European cannabis industry last month.

Read more
Market Diversification: Dr Reddy's plans to focus on China & US

(thehansindia.com)

Market Diversification: Dr Reddy's plans to focus on China & US

DRL plans to re-focus some of its Research and Development resources to service the high potential branded generics markets such as China, Russia and other emerging markets

Read more
IIT-BHU, DRL-DRDO to work jointly on medical, technical needs of security forces -

(hindustantimes.com)

IIT-BHU, DRL-DRDO to work jointly on medical, technical needs of security forces -

IIT-BHU, Varanasi signed an MoU with Defence Research Laboratory (DRL-DRDO), Tezpur Assam to foster the rate (speed) of drug discovery and development projects for military veterans to strengthen the defence front of India

Read more
Lupin plans expansion, aims to enter Chinese market in the next one year | Company News - Business Standard

(business-standard.com)

Lupin plans expansion, aims to enter Chinese market in the next one year | Company News - Business Standard

The company has now decided to focus on specialty drugs. The annual price cuts made the Japanese generics market unattractive

Read more

Never miss a headline about DRL

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages